Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis

AB Foundation25 enrolled

Overview

Miltefosine (longer course) will be used to try to improve the cure rate of mucosal leishmaniasis

Miltefosine (42 days) will be used to try to improve upon the cure rate with 28 days of drug for bolivian mucosal leishmaniasisi

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Sex: ALLMin age: 12 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Mucosal leishmaniasis Exclusion Criteria: * No comcomitant disease as judged by laboratory and clinical parameters

Palos Blancos

Palos Blancos, Bolivia

efficacy

safety

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.